Letter: tacrolimus may be hazardous in decompensated autoimmune liver disease with hyperbilirubinemia —authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1568-1569, June 2018.
Source: Alimentary Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: Y. S. de Boer
,
R. Liberal
,
M. A. Heneghan Source Type: research
More News: Autoimmune Disease | Drugs & Pharmacology | Liver | Liver Disease | Prograf | Tacrolimus | Urology & Nephrology